Cheng Du Sheng Nuo Biotec Co., Ltd.SSE: 688117

2025 Semi-annual Report

Aug 15, 2025 · Issued by Cheng Du Sheng Nuo Biotec Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Aug 15, 2025

On 6ix: 6ix.com/news/2025-semi-annual-report-387

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Cheng Du Sheng Nuo Biotec Co., Ltd. on 6ix

Earlier from Cheng Du Sheng Nuo Biotec

Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificate for Ganirelix InjectionJul 23, 2025
Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificate for Exenatide InjectionJul 1, 2025
Announcement on Voluntary Disclosure of 2025 Semi-annual Earnings PreannouncementJun 20, 2025
Announcement on Implementation of Dividend Distribution for 2024Jun 9, 2025
Announcement on Resolution of the 2024 Annual General MeetingMay 16, 2025

Later from Cheng Du Sheng Nuo Biotec

Announcement on Convening the 2025 Semi-annual Performance BriefingAug 22, 2025
Announcement on Shareholding Reduction Plan for Shareholders Holding Over 5% Shares, Partial Directors and Senior Management MembersAug 23, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% ScaleSep 18, 2025
Announcement on Voluntary Disclosure of Earnings Preannouncement for the First Three Quarters of 2025Oct 14, 2025
Indicative Announcement on Shareholder Terminating Concerted Action Relationship and Equity Change Reaching 1% ScaleOct 15, 2025

All Cheng Du Sheng Nuo Biotec news releases

Follow Cheng Du Sheng Nuo Biotec into a list and get an email when it puts out news.

Follow Cheng Du Sheng Nuo Biotec